Talus Bioscience Raises $11.2M to Develop Drugs Targeting Undruggable Gene-Regulating Proteins

Seattle biotech Talus Bioscience raised $11.2 million in venture capital to advance its drug discovery platform targeting undruggable gene-regulating proteins linked to diseases. Founded in 2020 by Alex Federation and Lindsay Pino, Talus uses its MARMOT platform and machine learning to study transcription factors within living cells.

More: Fierce Biotech, Talus Bio

No comments yet.